Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance
Jing‐Quan Wang, Yuqi Yang, Chao‐Yun Cai, et al.
Drug Resistance Updates (2021) Vol. 54, pp. 100743-100743
Closed Access | Times Cited: 172

Showing 1-25 of 172 citing articles:

Anticancer drug resistance: An update and perspective
Ruth Nussinov, Chung‐Jung Tsai, Hyunbum Jang
Drug Resistance Updates (2021) Vol. 59, pp. 100796-100796
Open Access | Times Cited: 239
Hypoxia as a driver of resistance to immunotherapy
Joanna Kopecka, Iris C. Salaroglio, Elisabeth Pérez‐Ruiz, et al.
Drug Resistance Updates (2021) Vol. 59, pp. 100787-100787
Open Access | Times Cited: 170
Therapeutic strategies to overcome taxane resistance in cancer
Tuyelee Das, Uttpal Anand, Swaroop Kumar Pandey, et al.
Drug Resistance Updates (2021) Vol. 55, pp. 100754-100754
Closed Access | Times Cited: 145
Glutathione-Related Enzymes and Proteins: A Review
Janka Vašková, Ladislav Kočan, Ladislav Vaško, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1447-1447
Open Access | Times Cited: 139
Novel nanomedicines to overcome cancer multidrug resistance
Zhenwei Su, Shaowei Dong, Shan‐Chao Zhao, et al.
Drug Resistance Updates (2021) Vol. 58, pp. 100777-100777
Closed Access | Times Cited: 134
Understanding and targeting resistance mechanisms in cancer
Zi‐Ning Lei, Tian Qin, Qiu‐Xu Teng, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 98
Long non-coding RNA mediated drug resistance in breast cancer
Deepshikha Singh, Yehuda G. Assaraf, Rajesh N. Gacche
Drug Resistance Updates (2022) Vol. 63, pp. 100851-100851
Closed Access | Times Cited: 83
Selenium and tellurium in the development of novel small molecules and nanoparticles as cancer multidrug resistance reversal agents
Enrique Domínguez‐Álvarez, Bálint Rácz, Małgorzata Anna Marć, et al.
Drug Resistance Updates (2022) Vol. 63, pp. 100844-100844
Open Access | Times Cited: 66
Targeting the tumor microenvironment: Potential strategy for cancer therapeutics
Quratulain Babar, Ayesha Saeed, Tanveer A. Tabish, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 6, pp. 166746-166746
Open Access | Times Cited: 44
Schiff bases and their metal complexes to target and overcome (multidrug) resistance in cancer
Ana Podolski-Renić, Ana Čipak Gašparović, Andreia Valente, et al.
European Journal of Medicinal Chemistry (2024) Vol. 270, pp. 116363-116363
Closed Access | Times Cited: 21
Tumor microenvironment targeted nano-drug delivery systems for multidrug resistant tumor therapy
Xinyue Shao, Xiaoling Zhao, Binghao Wang, et al.
Theranostics (2025) Vol. 15, Iss. 5, pp. 1689-1714
Open Access | Times Cited: 1
ATP‐binding cassette (ABC) transporters in cancer: A review of recent updates
Jing‐Quan Wang, Zhuo‐Xun Wu, Yuqi Yang, et al.
Journal of Evidence-Based Medicine (2021) Vol. 14, Iss. 3, pp. 232-256
Closed Access | Times Cited: 95
Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function
Lingyue Gao, Zhuo‐Xun Wu, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2021) Vol. 57, pp. 100770-100770
Closed Access | Times Cited: 93
Metal- and metalloid-based compounds to target and reverse cancer multidrug resistance
Andreia Valente, Ana Podolski-Renić, Isabella Poetsch, et al.
Drug Resistance Updates (2021) Vol. 58, pp. 100778-100778
Open Access | Times Cited: 76
Targeting multidrug resistance-associated protein 1 (MRP1)-expressing cancers: Beyond pharmacological inhibition
Kimberley M. Hanssen, Michelle Haber, Jamie I. Fletcher
Drug Resistance Updates (2021) Vol. 59, pp. 100795-100795
Closed Access | Times Cited: 68
The role of extracellular vesicles in the transfer of drug resistance competences to cancer cells
Cristina P. R. Xavier, Dimas Carolina Belisario, Rita Rebelo, et al.
Drug Resistance Updates (2022) Vol. 62, pp. 100833-100833
Open Access | Times Cited: 57
Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics
Maria Grazia Ferraro, Marialuisa Piccolo, Gabriella Misso, et al.
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 954-954
Open Access | Times Cited: 54
Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability
Giasemi C. Eptaminitaki, Dimitris Stellas, Benjamin Bonavida, et al.
Drug Resistance Updates (2022) Vol. 65, pp. 100866-100866
Closed Access | Times Cited: 49
Nanotechnology-based approaches overcome lung cancer drug resistance through diagnosis and treatment
Junnan Li, Lipeng Zhu, Hang Fai Kwok
Drug Resistance Updates (2022) Vol. 66, pp. 100904-100904
Closed Access | Times Cited: 48
Emerging Nanotherapeutic Approaches to Overcome Drug Resistance in Cancers with Update on Clinical Trials
Syed Nasir Abbas Bukhari
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 866-866
Open Access | Times Cited: 46
ABC transporters: human disease and pharmacotherapeutic potential
Jonathan M. Moore, Eric L. Bell, Robert Hughes, et al.
Trends in Molecular Medicine (2022) Vol. 29, Iss. 2, pp. 152-172
Open Access | Times Cited: 40
Targeting gamma-glutamyl transpeptidase: A pleiotropic enzyme involved in glutathione metabolism and in the control of redox homeostasis
Aleksandra Mitrić, Immacolata Castellano
Free Radical Biology and Medicine (2023) Vol. 208, pp. 672-683
Closed Access | Times Cited: 31
Nanomaterials as an advanced nano-tool for the Doxorubicin delivery/ Co-Delivery—A Comprehensive Review
Rabia Arshad, Muhammad Salman Arshad, Abbas Rahdar, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 83, pp. 104432-104432
Closed Access | Times Cited: 26
Overcoming Cancer Resistance to Platinum Drugs by Inhibiting Cholesterol Metabolism
Ying Wang, Linxiang Cai, Hui Li, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 42
Closed Access | Times Cited: 26
Photoactivated DNA Nanodrugs Damage Mitochondria to Improve Gene Therapy for Reversing Chemoresistance
Danyu Wang, Yi Hua, Shizhen Geng, et al.
ACS Nano (2023) Vol. 17, Iss. 17, pp. 16923-16934
Closed Access | Times Cited: 22
Page 1 - Next Page

Scroll to top